These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9067496)

  • 1. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance.
    Haidar MA; El-Hajj H; Bueso-Ramos CE; Manshouri T; Glassman A; Keating MJ; Maher A
    Am J Hematol; 1997 Mar; 54(3):189-95. PubMed ID: 9067496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression of MDM-2 in breast carcinomas.
    Bueso-Ramos CE; Manshouri T; Haidar MA; Yang Y; McCown P; Ordonez N; Glassman A; Sneige N; Albitar M
    Breast Cancer Res Treat; 1996; 37(2):179-88. PubMed ID: 8750585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
    Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
    Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in astrocytic gliomas and their correlation to cell proliferation.
    Dietzmann K; von Bossanyi P; Sallaba J; Kirches E; Synowitz HJ; Warich-Kirches M
    Gen Diagn Pathol; 1996 May; 141(5-6):339-44. PubMed ID: 8780933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
    Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
    Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mdm-2 oncoprotein in the primary and metastatic sites of mammary tumor (GI-101) implanted athymic nude mice.
    Rathinavelu P; Malavé A; Raney SR; Hurst J; Roberson CT; Rathinavelu A
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):133-46. PubMed ID: 10738909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
    Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
    Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and mdm-2 expression in malignant melanoma: an immunocytochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumors.
    Gelsleichter L; Gown AM; Zarbo RJ; Wang E; Coltrera MD
    Mod Pathol; 1995 Jun; 8(5):530-5. PubMed ID: 7675773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).
    Winkler D; Schneider C; Kröber A; Pasqualucci L; Lichter P; Döhner H; Stilgenbauer S
    Leukemia; 2005 Jul; 19(7):1211-5. PubMed ID: 15902296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Momand J; Zambetti GP; Olson DC; George D; Levine AJ
    Cell; 1992 Jun; 69(7):1237-45. PubMed ID: 1535557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
    Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
    Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangement and expression of MDM2 oncogene in chronic lymphocytic leukemia.
    Huang YQ; Raphael B; Buchbinder A; Li JJ; Zhang WG; Friedman-Kien AE
    Am J Hematol; 1994 Oct; 47(2):139-41. PubMed ID: 8092130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mdm-2 expression in human testicular germ-cell tumors and its clinical value.
    Eid H; Institoris E; Géczi L; Bodrogi I; Bak M
    Anticancer Res; 1999; 19(4C):3485-90. PubMed ID: 10629640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
    Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
    J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the MDM2 oncogene in leukemia and lymphoma.
    Watanabe T; Ichikawa A; Saito H; Hotta T
    Leuk Lymphoma; 1996 May; 21(5-6):391-7, color plates XVI following 5. PubMed ID: 9172803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
    Villaseca M; Araya JC; Roa I; Roa JC
    Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.